Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Cited In for PubMed (Select 14502008)

1.

Impact of elevated maternal HIV viral load at delivery on T-cell populations in HIV exposed uninfected infants in Mozambique.

de Deus N, Moraleda C, Serna-Bolea C, Renom M, Menendez C, Naniche D.

BMC Infect Dis. 2015 Feb 3;15(1):37. doi: 10.1186/s12879-015-0766-6.

2.

Fetal exposure to HIV-1 alters chemokine receptor expression by CD4+T cells and increases susceptibility to HIV-1.

Bunders MJ, van Hamme JL, Jansen MH, Boer K, Kootstra NA, Kuijpers TW.

Sci Rep. 2014 Oct 24;4:6690. doi: 10.1038/srep06690.

3.

Anaemia in pregnancy is associated with advanced HIV disease.

Nandlal V, Moodley D, Grobler A, Bagratee J, Maharaj NR, Richardson P.

PLoS One. 2014 Sep 15;9(9):e106103. doi: 10.1371/journal.pone.0106103. eCollection 2014.

4.

Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.

Kakkar F, Lamarre V, Ducruet T, Boucher M, Valois S, Soudeyns H, Lapointe N.

BMC Infect Dis. 2014 May 5;14:236. doi: 10.1186/1471-2334-14-236.

5.

HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Afran L, Garcia Knight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL.

Clin Exp Immunol. 2014 Apr;176(1):11-22. doi: 10.1111/cei.12251. Review.

6.

Safety of protease inhibitors in HIV-infected pregnant women.

Chougrani I, Luton D, Matheron S, Mandelbrot L, Azria E.

HIV AIDS (Auckl). 2013 Sep 27;5:253-62. doi: 10.2147/HIV.S33058. eCollection 2013. Review.

7.

Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants.

Dryden-Peterson S, Jayeoba O, Hughes MD, Jibril H, McIntosh K, Modise TA, Asmelash A, Powis KM, Essex M, Shapiro RL, Lockman S.

PLoS One. 2013 Sep 23;8(9):e74171. doi: 10.1371/journal.pone.0074171. eCollection 2013.

8.

Normal Thymic Size and Low Rate of Infections in Human Donor Milk Fed HIV-Exposed Uninfected Infants from Birth to 18 Months of Age.

Jeppesen DL, Ersbøll AK, Hoppe TU, Nielsen SD, Valerius NH.

Int J Pediatr. 2013;2013:373790. doi: 10.1155/2013/373790. Epub 2013 Apr 30.

9.

Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025.

Read JS, Huo Y, Patel K, Mitchell M, Scott GB.

J Pediatric Infect Dis Soc. 2012 Jun;1(2):92-102. Epub 2012 May 3.

10.

Hematological changes in women and infants exposed to an AZT-containing regimen for prevention of mother-to-child-transmission of HIV in Tanzania.

Ziske J, Kunz A, Sewangi J, Lau I, Dugange F, Hauser A, Kirschner W, Harms G, Theuring S.

PLoS One. 2013;8(2):e55633. doi: 10.1371/journal.pone.0055633. Epub 2013 Feb 6.

12.

Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants.

Siberry GK, Williams PL, Mendez H, Seage GR 3rd, Jacobson DL, Hazra R, Rich KC, Griner R, Tassiopoulos K, Kacanek D, Mofenson LM, Miller T, DiMeglio LA, Watts DH; Pediatric HIV/AIDS Cohort Study (PHACS).

AIDS. 2012 Jun 1;26(9):1151-9. doi: 10.1097/QAD.0b013e328352d135.

13.

Impaired humoral response to vaccines among HIV-exposed uninfected infants.

Abramczuk BM, Mazzola TN, Moreno YM, Zorzeto TQ, Quintilio W, Wolf PS, Blotta MH, Morcillo AM, da Silva MT, Dos Santos Vilela MM.

Clin Vaccine Immunol. 2011 Sep;18(9):1406-9. doi: 10.1128/CVI.05065-11. Epub 2011 Jul 20.

14.

Safety and tolerability of antiretrovirals during pregnancy.

Weinberg A, Forster-Harwood J, Davies J, McFarland EJ, Pappas J, Kinzie K, Barr E, Paul S, Salbenblatt C, Soda E, Vazquez A, Levin MJ.

Infect Dis Obstet Gynecol. 2011;2011:867674. doi: 10.1155/2011/867674. Epub 2011 Apr 11.

15.

Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.

Dryden-Peterson S, Shapiro RL, Hughes MD, Powis K, Ogwu A, Moffat C, Moyo S, Makhema J, Essex M, Lockman S.

J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):428-36. doi: 10.1097/QAI.0b013e31820bd2b6.

16.

Effect of Maternal HIV-1 Status and Antiretroviral Drugs on Haematological Profiles of South African Infants in Early Life.

Schramm DB, Anthony F, Mathebula B, Sherman G, Coovadia A, Gray GE, Kuhn L, Tiemessen CT.

Open AIDS J. 2010 Aug 12;4:156-65. doi: 10.2174/1874613601004010156.

17.

Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.

Williams PL, Marino M, Malee K, Brogly S, Hughes MD, Mofenson LM; PACTG 219C Team.

Pediatrics. 2010 Feb;125(2):e250-60. doi: 10.1542/peds.2009-1112. Epub 2010 Jan 18.

18.

Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.

Ciaranello AL, Seage GR 3rd, Freedberg KA, Weinstein MC, Lockman S, Walensky RP.

AIDS. 2008 Nov 12;22(17):2359-69. doi: 10.1097/QAD.0b013e3283189bd7.

19.

Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.

Bae WH, Wester C, Smeaton LM, Shapiro RL, Lockman S, Onyait K, Thior I, Essex M.

AIDS. 2008 Aug 20;22(13):1633-40. doi: 10.1097/QAD.0b013e328307a029.

20.

High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothers.

Durand-Gasselin L, Pruvost A, Dehée A, Vaudre G, Tabone MD, Grassi J, Leverger G, Garbarg-Chenon A, Bénech H, Dollfus C.

Antimicrob Agents Chemother. 2008 Jul;52(7):2555-63. doi: 10.1128/AAC.01130-07. Epub 2008 Apr 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk